KELSEY PEDLEY: Open Payments
NPI 1679930499 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,477 in 174 payments from 24 companies in 2025. Trend: 2023 $1,983 · 2024 $2,308 · 2025 $2,477
Food & beverage: $2,477
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 25 | $369 |
| ABBVIE INC. | 25 | $349 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $195 |
| AstraZeneca Pharmaceuticals LP | 3 | $190 |
| PFIZER INC. | 20 | $163 |
| Amgen Inc. | 14 | $163 |
| Axsome Therapeutics, Inc. | 13 | $161 |
| Lilly USA, LLC | 10 | $154 |
| Lundbeck LLC | 10 | $145 |
| GlaxoSmithKline, LLC. | 4 | $75 |
Products named: UBRELVY, CAPLYTA, Wegovy, REXULTI, Ozempic, JARDIANCE, AIRSUPRA, Auvelity.
Industry payments across KY — which companies pay providers there.
